Health News

The way prostate cancer develops in men who have an altered ‘breast cancer gene’ is the same route by which breast cancer develops in women with the same mutation, reveals a study published in PLoS Genetics today (Thursday).

Read more

Filed under: Pharmacy News
Tags: Breast Cancer, cancer, Genetic, Pharmacy, Prostate Cancer

Related posts

• Researchers find genetic variants that cause arthritis in breast cancer patients taking aromatase inhibitors (0)
  Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of [...]
  
  
• NYT Examines Challenges To Improving ‘Personalized Medicine’ For Breast Cancer, Other Diseases (0)
  The New York Times on Tuesday examined how improvements in genetic testing could affect "personalized medicine" for the treatment of breast cancer and other diseases in the future. Personalized medicine uses genetic screening and other tests to provide physicians with more information to tailor patients' treatments, the Times reports. Read more [tags] Pharmacy News [/tags]
  
  
• Novel therapy slows tumor growth in 85% of advanced breast cancer patients: Study (0)
  A novel therapy designed to attack tumors in patients with a genetic mutation in either BRCA1 or BRCA2, slowed tumor growth in 85 percent of advanced breast cancer patients treated in a small study, researchers report in the July 6 issue of The Lancet. Read more [tags] Pharmacy News [/tags]
  
  
• New dietary supplement blocks triggering mechanism causing breast cell mutations (0)
  Every 13 minutes a woman loses her battle with breast cancer and in 2009 alone more than 27,000 men died from prostate cancer. These powerful statistics continue to fuel research and new developments. With tens of millions of dollars in financial support from the National Cancer Institute and the U.S. Department of Defense, scientists have [...]
  
  
• Medicare to cover 2 expensive cancer drugs (0)
  Medicare confirmed on Thursday that it would continue to pay for two expensive cancer drugs that had been at the center of debate — Avastin from Genentech for breast cancer and Provenge from Dendreon for prostate cancer. Read more [tags] Pharmacy News [/tags]